"Het Algemeen Stedelijk Ziekenhuis staat voor maatschappelijk verantwoorde, veilige en innovatieve gezondheidszorg voor u en in overleg met uw zorgpartners. Het ASZ biedt medische en verpleegkundige zorg op drie locaties: Aalst, Geraardsbergen en Wetteren. Meer informatie kunt u terugvinden op onze website."

During the past decade, ASZ Aalst conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 10 clinical trials were completed, i.e. on average, 32.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 3 clinical trials were completed. i.e. 23.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ASZ Aalst" #1 sponsor was "University Hospital, Ghent" with 11 trials, followed by "Amgen" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASZ Aalst" #1 collaborator was "AZ Sint-Jan AV" with 2 trials as a collaborator, "Medri" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Universiteit Antwerpen" with 2 trials as a collaborator and "A.O. Ospedale Papa Giovanni XXIII" with 1 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "ASZ Aalst" are "Rheumatoid Arthritis" (7 trials), "Atrial Fibrillation" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Cardiovascular Disease" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "ASZ Aalst" in a lesser frequency.

Most popular intervention types in "ASZ Aalst" are "Drug" (22 trials), "Other" (11 trials), "Procedure" (9 trials), "Device" (8 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Evolocumab" (2 trials), "Tocilizumab" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "etanercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "ASZ Aalst" are 45 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ASZ Aalst". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in ASZ Aalst, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in ASZ Aalst, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 16 trials that are defined as “Not Applicable".